Global API Market Forecast to 2017
DUBLIN, August 9, 2013 /PRNewswire/ –
Research and Markets (
http://www.researchandmarkets.com/research/92hzrx/global_api_market) have announced
the addition of the “Global API Market Forecast to 2017″
[http://www.researchandmarkets.com/research/92hzrx/global_api_market ] report to their
The market for Active Pharmaceutical Ingredients is brimming with activities. While it
is consolidating in US and EU resulting in the emergence of few big players producing
specialty APIs that target high value markets, new players are entering in the mass
markets of India and China. With global healthcare spending to have reached around US$ 6.4
trillion in 2010 and a rapidly ageing population boosting the demand for pharmaceuticals,
APIs represent one of the most exciting markets for growth.
In their latest research study, “Global API Market Forecast to 2017″, the authors
identified market dynamics in various important regions to highlight the areas offering
promising possibilities for companies to boost their growth. The market, which stood at
US$ 113 billion in 2012, is expected to grow at a CAGR of around 8% during 2012-2017.
For our study, we have analyzed the global API market from different perspectives. It
has been studied at the Captive vs. Merchant level; Branded vs. Generic level and
Synthetic vs. Biotech level. This has been done to provide a thorough and apt assessment
to players who can use the research findings to support their business strategies.
At the regional level, the authors have provided a thorough understanding of the
merchant API markets [http://www.researchandmarkets.com/research/92hzrx/global_api_market
] along with their future outlook to 2017. Each region’s market is unique with exports
playing a major role in regions of India and China. Each region’s regulatory environment
has also been elaborated, while discussing various drivers and challenges, to help new
entrants overcome entry barriers. The report also provides a comparative analysis of key
regions highlighting labor cost and productivity; price structure with reference to
manufacturing indicators of profit margins, raw materials and conversion costs; and
investment incurred in plant setups. These research findings will aid international
players to strategically expand their presence globally.
- Aurobindo Pharma Limited - BASF SE - Boehringer Ingelheim GmbH - Cambrex Corporation - Cipla - Daiichi Fine Chemicals - Divis Laboratories Limited - Dr Reddy's Laboratories - Fabbrica Italiana Sintetici - GlaxoSmithKline - Lonza - Pfizer CentreSource - Ranbaxy Laboratories - Royal DSM - Teva Active Pharmaceutical Ingredients - Zhejiang Hisun Pharmaceutical Co. Ltd.
For more information visit
About Research and Markets
Research and Markets is the world’s leading source for international market research
reports and market data. We provide you with the latest data on international and regional
markets, key industries, the top companies, new products and the latest trends.
Research and Markets Laura Wood, Senior Manager. firstname.lastname@example.org U.S. Fax: +1-646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Healthcare and Medical Devices [http://www.researchandmarkets.com/categories.asp?cat_id=12&campaign_id=92hzrx ]
SOURCE Research and Markets